drug combining

Go Take the 2022 Global Drug Survey

At the end of every year the Global Drug Survey opens up, inviting people from around the world to take part in the world’s biggest anonymous drug survey.

Since its inaugural run in 2014, the survey data has revealed information about new substance use trends, helping to guide the development of saner drug policies and distributing up-to-date harm reduction tips and techniques.

In addition to asking the usual questions, this year the Global Drug Survey is focusing on a few new topics: how drug laws impact drug users, mixing tobacco with cannabis, no- and low-alcohol drinks, sex and psychedelics, drink spiking, and illicit tobacco.

If you’ve taken drugs this year then you should fill out this survey. It can take a while to complete, especially if you’ve used a wide variety of substances, but the data will contribute to a better understanding of how the world uses drugs and educate people on how to use them in the safest possible way. On average, it takes roughly 20 minutes to finish the survey but it took me about 45 minutes this year.

Time is quickly running out so you better jump on it fast if you want to participate because the submission period ends on December 31st. And stay tuned—the survey results are expected to come out in May 2022.

This Week in Psychedelics - 12.17.21

Cannabis

  • Malta becomes first EU country to legalise cannabis for personal use (Euronews)

  • St. Louis Mayor Signs Bill To Decriminalize Marijuana Possession And Cultivation (Marijuana Moment)

  • No Fentanyl Found in Cannabis After All, Vermont Police Say (High Times)

  • Viral story shared across social media about two teens overdosing on fentanyl-laced marijuana in Springfield was untrue (MassLive)

  • Ministry pushes full cannabis legalisation (Bangkok Post)

  • Government-Funded Study Shows Unprecedented Decline in Marijuana Use By Young People (NORML)

  • Pfizer to Acquire Pharmaceutical Company Testing Cannabinoid Treatment (High Times)

  • Heavy metals in cannabis plants could affect human health, study finds (New Atlas)

  • Rhode Island Legalization Bill Set for Early 2022 Introduction (High Times)

  • Baltimore: City Officials Move to Abolish Pre-Employment Drug Screens for Many Public Employees (NORML)

  • Smoking CBD-Rich Marijuana Has ‘No Significant Impact’ On Driving Ability, Study Finds (Marijuana Moment)

  • Cannabis use could cause harmful drug interactions (ScienceDaily)

LSD

  • Cary Grant Is High on LSD in ‘Flying Over Sunset.’ Everyone Else Has a Bad Trip. (The Daily Beast)

  • PharmaTher Announces Positive Research Results for LSD Microneedle Patch (BioSpace)

  • MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHD (Psilocybin Alpha)

Magic Mushrooms

  • New Filing Challenges Compass Pathways’ Infamous Patent on Synthetic Psilocybin (VICE)

  • Psilocybin-assisted psychotherapy reduces loss of meaning and suicidal ideation among cancer patients (PsyPost)

  • With health care workers hurting, a doctor wants to see if a psychedelic can help (NBC News)

  • COMPASS Pathways announces positive outcome of 25mg COMP360 psilocybin therapy as adjunct to SSRI antidepressants in open-label treatment-resistant depression study (Psilocybin Alpha)

  • More patients granted psilocybin exemption by federal government (CBC)

  • Warning: Oregon Legalized Supported Adult Use of Psilocybin, Not Psychedelic Therapy (Chacruna)

  • New York Lawmaker Files Bill To Legalize Medical Psilocybin Treatments, With Focus On First Responders And Veterans (Marijuana Moment)

  • This Trippy New Book Takes You Through Modern Mushroom History—With Cartoons (DoubleBlind)

  • Psyched Wellness Announces Path to Market for AME-1-derived Products in the USA (Psilocybin Alpha)

  • Silo Wellness announces series of psilocybin retreats in Jamaica (Globetrender)

  • HAVN Life Successfully Exports Psilocybin from Jamaica Facility into the U.S. for Research Purposes (Psilocybin Alpha)

MDMA

  • The Big Return – and Decline in Quality – of MDMA (VICE)

  • Latest trials confirm the benefits of MDMA – the drug in ecstasy – for treating PTSD (The Conversation)

  • MDMA could soon be used to treat PTSD according to physicians (Mixmag)

Ayahuasca

  • Study links the ceremonial use of ayahuasca to robust reductions in neuroticism (PsyPost)

  • Educating Gringos in Shipibo Ways (Chacruna)

  • Esther Jean Langdon: Half a Century of Research About Shamanism and Ayahuasca (Chacruna)

Novel Psychoactive Substances

  • Cybin Awarded Notice of Allowance from U.S. Patent and Trademark Office for CYB004 (Deuterated Psychedelic Tryptamine) for the Treatment of Anxiety Disorders (Psilocybin Alpha)

  • atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial of RL-007 in Cognitive Impairment Associated with Schizophrenia (Psilocybin Alpha)

Synthetic Cannabinoids

  • Tainted synthetic marijuana linked to severe bleeding cases in Florida (Live Science)

Miscellaneous

  • Psychedelics Rejected for Therapeutic Use in Australia (VICE)

  • Can a Values-Centered Psychedelic Ecosystem Effectively Compete? (Lucid News)

  • Mind Medicine Australia’s Response to the Announcement of the TGA NOT to Reschedule the Medical Use of MDMA for Treatment Resistant PTSD and the Medical Use of Psilocybin for Treatment Resistant Depression as Part of Therapy. (Mind Medicine Australia)

  • How Do Psychedelics Change Your Personality? These Researchers Tried To Find Out (IFLScience)

  • ‘This isn’t the 60s again’: psychedelics business takes off amid culture clash (The Guardian)

  • 2022 Global Drug Survey: Help make it bigger than ever for its 10 year anniversary (TalkingDrugs)

  • Most Addiction Specialists Support Legalized Therapeutic Psychedelics (Medscape)

  • Psychedelic-Assisted Therapy on the Rise in VA Hospitals (Lucid News)

  • Psychedelics and Substance Use Disorder: 4000 BCE to Present Day (Psychedelic Science Review)

  • Many Indians Are Experimenting With Psychedelics, Other Drugs to Deal With Mental Health Issues (The Swaddle)

  • Editor’s Choice Award 2021-Best Study on Psychedelics and Neuroplasticity (Psychedelic Science Review)

  • atai Impact Establishes the atai Fellowship Fund in Psychedelic Neuroscience with Massachusetts General Hospital’s Center for the Neuroscience of Psychedelics (Psilocybin Alpha)

  • How to Start Microdosing Psychedelics (DoubleBlind)

  • Understanding HPPD to Prioritize Harm Reduction of a Very Real Psychedelic Risk (Psychedelic Spotlight)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.12.21

Cannabis

  • Top Mexican Senator Says There’s Agreement To Prioritize Marijuana Legalization Legislation This Session (Marijuana Moment)

  • Germany’s Next Coalition Nears Deal on Legalizing Cannabis (Bloomberg)

  • Texas judge allows legal sale of delta-8 products—for now (Leafly)

  • New York adopts final rules banning delta-8 THC, smokable hemp (HempToday)

  • Another Poll Shows Majority Support For Marijuana Legalization, Including Most Republicans (Marijuana Moment)

  • Herbal Supplement Giant To Enter THC, Psychedelics Industries, Seeking To Become First Household Brand To Do So (Forbes)

  • This MMA fighter is taking on cannabis stigma in sports (Leafly)

  • What Happens When You Mix Cannabis With Psychedelics? (IFLScience)

  • Marijuana Legalization In Canada Did Not Result In Increased Traffic Injuries, Study Finds (Marijuana Moment)

  • Medical Cannabis for Epilepsy - Research Summary and Recommendations (Drug Science)

  • Medical Cannabis Sales Finally Set to Begin in West Virginia (NORML)

  • South Dakota Marijuana Activists Delay Legalization Signature Delivery After Missing Initial Deadline (Marijuana Moment)

  • Cannabis requires more water than commodity crops, researchers say (Marijuana Business Times)

LSD

  • Sweden Experimenting With Rats on LSD to Cure Depression, Addiction (Sputnik News)

  • How Likely Are Bad Trips and Flashbacks from LSD? (Psychedelic Science Review)

  • Blackhawk Growth's MindBio Therapeutics Completes Safety Milestone in its Phase 1 Clinical Trials (Yahoo!)

Magic Mushrooms

  • Largest psychedelic therapy trial to date delivers mixed results (New Atlas)

  • Nonprofit Hosts Canada’s First Legal Psilocybin Group Therapy (Truffle Report)

  • Australian Therapists to Be Given Psilocybin to Better Understand Their Patients (VICE)

  • Denver City Council Considers Expanding Psilocybin Decriminalization (Marijuana Moment)

  • Psilocybin therapy boosts cognitive and neural flexibility in depressed patients, study finds (PsyPost)

  • A Look at Connecticut’s Psilocybin Study Workgroup (Truffle Report)

MDMA

  • Doctor takes bid to treat patient with MDMA to court, in first case of its kind in Australia (Australian Broadcasting Corporation)

  • The Story Behind the 'First Ever Ecstasy Song' (VICE)

  • Expert: MDMA Is Very Likely to Be FDA-Approved for PTSD by the End of 2023 (Pharmacy Times)

  • Veteran Who Cured PTSD with MDMA-Assisted Therapy Wows NBC ‘Today’ Show Anchors (Psychedelic Spotlight)

  • Numinus to Host Extension of MAPS-Sponsored MDMA-Assisted Therapy for PTSD Trials (PR Newswire)

Ayahuasca

  • A cancer doctor said doing ayahuasca saved his marriage and relationship with his 2 young children (Yahoo!)

Novel Psychoactive Substances

  • Pre-Clinical Data Shows Cybin’s Novel Analog Could Have Advantages Over Psilocybin (Forbes)

  • Forgotten Psychedelics: What Is 2C-B? (Psychedelic Spotlight)

Ketamine

  • Baby Girl Died From 'Acute Ketamine Intoxication,' and Prosecutors Charge Washington Father With Murder (The Daily Chronicle)

  • Single Infusion of Ketamine Rapidly Reduces Suicidal Thoughts (Medscape)

  • Warning of ‘wild west’ in depression treatment as UK clinics offer ketamine (The Guardian)

  • Psychedelics Wellness Scores Big Win With New Mainstream Deal (Forbes)

Miscellaneous

  • DEA Boosts Psilocybin, MDMA And DMT Production Levels Again In Final Quotas For 2021 (Marijuana Moment)

  • New Website Details Abuse Allegations Against German Psychedelic Practitioners (Psymposia)

  • Big Tech's Psychedelics Grift (WIRED)

  • Prosecutors seek 4+ years in prison for 'QAnon Shaman' in attempt to set example (CNN)

  • Will the magic of psychedelics transform psychiatry? (The Guardian)

  • Veterans Have Become Unlikely Lobbyists in Push to Legalize Psychedelic Drugs (The New York Times)

  • Psychedelics Could Become Extractive Capitalism—Unless We Hold Stakeholders Accountable (DoubleBlind)

  • Tim Ferriss Funds Fellowships for Journalists Reporting On Psychedelics (Lucid News)

  • 6 Ways the Psychedelic Space Can Divest From Whiteness (DoubleBlind)

  • Is Microdosing a Placebo? Here’s what our Head of Research Says (The Third Wave)

  • Countries not adequately addressing illegal drug use: Experts (The Straits Times)

  • Startup offers psychedelic-assisted mental wellness therapies (Axios)

  • The Masters of Bad Trips (Psymposia)

  • Monash University announces establishment of the Neuromedicines Discovery Centre to Focus on Psychedelic-Assisted Therapies for the Treatment of Key Classes of Mental Illness (Mind Medicine Australia)

  • Psychedelic Company Lists on NASDAQ as ‘DRUG’ (High Times)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.5.21

Cannabis

  • Voters In Seven Ohio Cities Approve Marijuana Decriminalization Ballot Measures, With Seven Others Defeated (Marijuana Moment)

  • 3 Years Since the UK Legalised Medical Cannabis, and Only 3 NHS Prescriptions (Drug Science)

  • New Congressional Report Provides Pathway for How the Biden Administration Can Deschedule Marijuana and Issue Blanket Pardons to Past Offenders (NORML)

  • Pakistan Vows Cannabis Reform by End of Year (High Times)

  • Strong Majority Of Americans Continues To Support Marijuana Legalization At Record High Level, New Gallup Poll Finds (Marijuana Moment)

  • California legalized weed five years ago. Why is the illicit market still thriving? (The Guardian)

  • Philadelphia Voters Approve Marijuana Referendum Calling For Statewide Legalization (Marijuana Moment)

  • Virginia: Election Outcomes Likely to Influence Marijuana Legalization Launch (NORML)

  • DEA Emboldens Delta-8 Hemp Businesses By Signaling That The Cannabinoid Is Federally Legal (Marijuana Moment)

  • Marijuana Legalization Is Not Associated With Increased Mental Illness Or Suicide, New Study Finds, Despite Opposition Claims (Marijuana Moment)

  • Mississippi Governor Stalls Medical Cannabis Bill (High Times)

  • Legalizing Marijuana Reduces ‘Race-Based Arrests,’ American Medical Association Study Finds (Marijuana Moment)

  • Cannabis growers eye drought-resistant strains to cope with water shortage (Marijuana Business Daily)

  • Arkansas Activists File New Marijuana Legalization Initiative For 2022 Ballot (Marijuana Moment)

  • Medical marijuana could ease anxiety, depressive symptoms, study shows (Marijuana Business Daily)

  • Concentrates and vape products maintain dominance among heavy cannabis users (Marijuana Business Daily)

  • Government-Grown Marijuana Is Genetically Closer To Hemp Than Cannabis Sold In Dispensaries, Another Study Finds (Marijuana Moment)

  • Edibles and beverages are popular choices with new cannabis users (Marijuana Business Daily)

  • Army Recruits Who’ve Used Marijuana ‘Perform No Worse’ Than Other Soldiers, Military-Funded Report Finds (Marijuana Moment)

Magic Mushrooms

  • World-first trial of psilocybin therapy for anxiety disorders to begin in Australia (Happy Mag)

  • Psilocybin-assisted psychotherapy might help to reduce attachment anxiety (PsyPost)

  • Microdosing Moms: Psilocybin & Postpartum Depression Relief (Truffle Report)

  • COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy for PTSD (Psilocybin Alpha)

  • Psilocybe subaeruginosa: Australia’s Most Famous Magic Mushroom (DoubleBlind)

  • A Case Study on Microdosing and Self-Care (The Third Wave)

  • Psyched Wellness Announces That the Amanita Muscaria Mushroom Has Been Successfully Added to the Natural Health Products Ingredients Database (NHPID) of Canada (Psilocybin Alpha)

  • The Missing Mushroom: Psychedelic Science and the Future of Psilocybin (Psychedelic Science Review)

  • Braxia Scientific Graduates First Cohort of Medical Professionals from Psilocybin-Assisted Therapy Training Program; Ready to Start Health Canada Approved Psilocybin Clinical Trial (Psilocybin Alpha)

  • Filament Health Announces FDA Authorization of Clinical Trial with First-Ever Direct Psilocin Administration and First-Ever Psychedelic Botanical Drug Candidates (Psilocybin Alpha)

DMT

  • Algernon Pharmaceuticals Establishes 6 hours as Optimum Treatment Period for DMT in Neuron Study (Psilocybin Alpha)

  • PharmaDrug Advances Psychedelics Program with Analogue DMT Formulations to Treat Eye Diseases (Psilocybin Alpha)

  • Understanding A DMT Trip: From The Experience To Potential Side Effects (Healing Maps)

Mescaline

  • Mescaline Revelations: Hume, Buddhism, and the Illusory Nature of the Self (Sam Woolfe)

Peyote

Iboga

  • Ibogaine and Iboga: Traditional Use, Conservation, and Ethical Considerations (DoubleBlind)

Morning Glory Seeds

Novel Psychoactive Substances

  • atai Life Sciences Announces Supportive Interim Data from First 8-Patient Cohort of Phase 2a Trial for Novel Treatment of Cognitive Impairment Associated with Schizophrenia (Psilocybin Alpha)

Ketamine

  • Ketamine rapidly improves cognitive function, making those in suicidal crisis less likely to harm themselves (Medical Xpress)

  • Kernel’s Brain-Imaging Helmet Approved For Clinical Trial On Patients Using Ketamine (Forbes)

  • Klarisana's Newest Ketamine Study Shows IM Ketamine Therapy Comparable to IV Administration (PR Newswire)

  • Study: Mixing CBD With Ketamine Might Be Great For Depression (Forbes)

  • Ketamine Users Can Ensure Safety with DanceSafe’s New Testing Kit (Lucid News)

  • Parents Are Very Open to Ketamine Therapy for Kids, Study Finds (Psychedelic Spotlight)

DXM

  • ‘Robotripping’: Perth teens creating cough syrup cocktails as they chase a cheap high (The Age)

Miscellaneous

  • Detroit Voters Decriminalize Psychedelics, Joining Ann Arbor (DoubleBlind)

  • FDA Approves First Clinical Trial Using Naturally Sourced Psychedelics (Psychedelic Spotlight)

  • The False Promise of Psychedelic Utopia (VICE)

  • Classic Psychedelics Aren’t Addictive (Discover Magazine)

  • Psychedelic Therapy Is Hyped, But It’s Not Risk-Free: How Therapy Abuse Can Retraumatize Clients (Forbes)

  • New Orleans shoeshine man wins legal battle over $30,000 seized by DEA agents (NBC News)

  • Washington D.C.’s 1st Year of Psychedelic Decrim (Truffle Report)

  • Statewide Psychedelic Decriminalization Efforts Are Growing Across the Nation (Lucid News)

  • PharmaTher Provides Research Update on Microneedle Patch Delivery Technologies for Psychedelics (Yahoo!)

  • Wonderland: Miami Takes Shape as the Largest Psychedelic Medicine Business Event (High Times)

  • Oregon’s Drug Decriminalization Has Raised Over $300 Million for Treatment and Services (Filter)

  • ‘I’ve experienced states of consciousness beyond this life’: The people turning to psychedelics on their deathbeds (The Independent)

  • How the Psychedelic Community Should Respond to Sexual Abuse (Lucid News)

  • Psychedelic Research Beyond Depression & Trauma Part II (Truffle Report)

  • Science Has Shown Me the Way Ahead with Psychedelics (Chacruna)

  • We must address and deconstruct the stigma of psychedelics (The Michigan Daily)

  • How Psychedelics Help with Parenting (Reality Sandwich)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.8.21

ThisWeekinPsychedelics.png

Cannabis

  • Philadelphia Will Vote On Marijuana Referendum Calling For Statewide Legalization Next Month (Marijuana Moment)

  • Top Mexican Senator Lays Out Next Steps For National Marijuana Legalization (Marijuana Moment)

  • Nevada: New Marijuana Laws Took Effect This Month (NORML)

  • Portugal Delays Recreational Cannabis Bills as Luxembourg Also Signals Delay (High Times)

  • New York: Regulators Approve Patients’ Access to Medical Cannabis Flower (NORML)

  • NBA Won’t Randomly Drug Test Players For Marijuana For Another Season, League Announces (Marijuana Moment)

  • Lung Injuries Tied To Contaminated Vapes Were Less Common In States With Legal Marijuana And Homegrow, Study Finds (Marijuana Moment)

  • California Legalizes Smokable Hemp and Food Sales in Historic Bill (High Times)

  • Preconception cannabis use linked to an increased risk of postpartum depression (PsyPost)

  • More Than A Dozen Ohio Cities Will Vote On Marijuana Decriminalization Ballot Measures Next Month (Marijuana Moment)

  • CBGA More Effective For Seizures Than CBD, Study of Mice Finds (High Times)

  • Study: Cannabis Use Disorder Diagnosis Associated with Greater Risk of COVID Breakthrough Infections — NORML Responds (NORML)

  • Bipartisan Pennsylvania Senators Unveil Marijuana Legalization Bill Amid Whirlwind Of Reform Efforts In The State (Marijuana Moment)

  • Oklahoma Activists File Marijuana Legalization And Medical Cannabis Reform Initiatives For 2022 Ballot (Marijuana Moment)

LSD

Magic Mushrooms

  • GOP Pennsylvania Lawmaker Files Psilocybin Research Bill For Veterans And First Responders (Marijuana Moment)

  • Denver may ease magic mushrooms laws further two years after decriminalization (The Denver Post)

  • Is Denver’s Psilocybin Decriminalization Having an Impact? (Filter)

  • Psychedelic drug changes the emotional state of people listening to music (News-Medical.net)

  • "Homebrew" Psilocybin Created By Scientists Using "Widely Available" Materials (IFLScience)

  • Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr. Matthew Johnson (Mydecine)

  • Psygen Announces use of Psilocybin in Human Trial and Provides Update on IP Portfolio (Psilocybin Alpha)

  • Psyched Wellness Announces Commencement of Next Pre-Clinical Study on AME-1 (Psilocybin Alpha)

MDMA

  • Why You Vom When You’re Coming Up On MDMA (VICE)

  • MDMA-assisted psychotherapy associated with sleep improvements among PTSD patients (PsyPost)

Peyote

  • Santa Cruz Removes Peyote And Other Mescaline-Containing Cacti From Psychedelics Decriminalization Law (Marijuana Moment)

Novel Psychoactive Substances

Ketamine

  • Recreational ketamine use has increased in recent years, but remains rare (Medical Xpress)

  • PharmaTher Initiates Phase 2 Clinical Trial of Ketamine for the Treatment of Parkinson’s Disease (Psilocybin Alpha)

Miscellaneous

  • Seattle Becomes Largest U.S. City To Decriminalize Psychedelics (Marijuana Moment)

  • Arcata, California Decriminalizes Psychedelics (Truffle Report)

  • The Psychedelics Industry Could Offer a Whole New Approach to Work (Rolling Stone)

  • Will Smith Recalls Life-Changing Psychedelic Experiences in New Book (High Times)

  • PSYCH Publishes Third Edition of The Psychedelics as Medicine Report (PR Newswire)

  • Toronto’s Bid to Decriminalize Drugs Hangs in the Balance (Filter)

  • The Need for New Psychedelic Compounds (Psychology Today)

  • Risks of Serotonin Syndrome when Combining Psychedelics with Antidepressants (Chacruna)

  • The 'Psychedelic Renaissance' Is Entirely About Corporate Greed (Caitlin Johnstone)

  • Becoming a Yes-Sayer: Psychedelics, Nietzsche, and the Affirmation of Life (Sam Woolfe)

  • Will Psychedelic Companies Embrace Indigenous Reciprocity? (Lucid News)

  • What Is Hallucinogen-Persisting Perception Disorder (HPPD)? (PsychCentral)

  • Anima Mundi: Psychedelics and The Ensouled Earth (Psychedelics Today)

  • Ensuring Equity in Psychedelic Science and Businesses (Truffle Report)

  • Death and psychedelics: How science is reviving this ancient connection (Leafly)

  • DoubleBlind Claims Its Ad Was the ‘First-Ever’ U.S. Psychedelic Destigmatization Campaign — It Wasn’t (Psymposia)

  • Psychedelic-Induced Psychological Flexibility Can Reduce Racial Trauma (Truffle Report)

  • Tryp Therapeutics Announces Collaboration with Researchers at the University of Wisconsin-Madison (Psilocybin Alpha)

  • Psychedelics and Mental Health Therapy in Colorado: DORA and Potential Regulatory Response (JD Supra)

  • Psychedelics and Perception Part 2: The First Era of Research (Psychedelic Science Review)

  • It’s one big mistake (New Amsterdam Psychedelic Law)

  • Madison Margolin Sounds Off on Mainstreaming of Cannabis and Psychedelics Cultures (CelebStoner)

  • Numinus Upgrades Psychedelics Lab to Increase Research Service Capabilities (PR Newswire)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.